| Kodiak Sciences, Inc. (KOD) | 3.34% | $526.24M | N/A | N/A | N/A |
| Renovaro, Inc. (ENOB) | 2.78% | $260.30M | N/A | N/A | N/A |
| uniQure NV (QURE) | 2.51% | $745.77M | 62.54% | -75.21% | 10.47 |
| Poseida Therapeutics, Inc. (PSTX) | 2.47% | $921.04M | 667.19% | 98.19% | 0.86 |
| AVROBIO, Inc. (AVRO) | 2.13% | $714.52M | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (CRTX) | 2.01% | $86.68M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 1.92% | $72.22M | 58.86% | 73.65% | 1.67 |
| Sangamo Therapeutics, Inc. (SGMO) | 1.79% | $406.86M | 425.77% | 95.70% | 3.33 |
| Verastem, Inc. (VSTM) | 1.53% | $222.53M | N/A | N/A | 6.95 |
| InflaRx NV (IFRX) | 1.42% | $147.21M | 105.64% | 68.59% | 143.61 |
| Graphite Bio, Inc. (GRPH) | 1.34% | $933.24M | N/A | N/A | N/A |
| MeiraGTx Holdings Plc (MGTX) | 1.32% | $489.24M | 113.80% | -39.73% | 18.85 |
| Seer, Inc. (California) (SEER) | 1.31% | $150.36M | -3.12% | 48.07% | -7.01 |
| Monte Rosa Therapeutics, Inc. (GLUE) | 1.28% | $579.96M | N/A | 77.18% | 15.77 |
| Athira Pharma, Inc. (ATHA) | 1.27% | $24.04M | N/A | N/A | N/A |
| ImmuCell Corp. (ICCC) | 1.20% | $43.58M | 11.40% | 26.34% | 1.74 |
| SAB Biotherapeutics, Inc. (SABS) | 1.10% | $39.23M | -100.00% | N/A | -0.58 |
| CorMedix, Inc. (CRMD) | 1.10% | $557.02M | N/A | 94.01% | 35.05 |
| Aadi Bioscience, Inc. (AADI) | 1.09% | $58.91M | 21.03% | 88.85% | -0.24 |
| Xeris Biopharma Holdings, Inc. (XERS) | 1.08% | $533.71M | 12.31% | 69.96% | 3.34 |
| Spruce Biosciences, Inc. (SPRB) | 1.08% | $22.18M | -80.41% | 98.34% | -5.24 |
| Kezar Life Sciences, Inc. (KZR) | 1.07% | $50.71M | -100.00% | N/A | N/A |
| Ventyx Biosciences, Inc. (VTYX) | 1.06% | $196.58M | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX) | 1.05% | $45.09M | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL) | 1.04% | $967.37M | N/A | N/A | N/A |
| Taysha Gene Therapies, Inc. (TSHA) | 1.03% | $516.46M | -62.33% | 83.22% | 44.65 |
| Passage Bio, Inc. (PASG) | 1.03% | $48.95M | N/A | N/A | N/A |
| Altimmune, Inc. (ALT) | 1.02% | $685.64M | -98.62% | -640.00% | 5,746.38 |
| Nascent Biotech, Inc. (NBIO) | 1.02% | $9.32M | N/A | N/A | N/A |
| Mersana Therapeutics, Inc. (MRSN) | 1.01% | $306.36M | 63.65% | 96.81% | 3.11 |
| Leap Therapeutics, Inc. (LPTX) | 1.00% | $121.08M | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN) | 0.99% | $374.83M | N/A | N/A | N/A |
| Vor Biopharma, Inc. (VOR) | 0.99% | $69.36M | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR) | 0.96% | $70.82M | 11.94% | 49.70% | 1.39 |
| Elutia, Inc. (AZYO) | 0.94% | $148.27M | -3.35% | 46.29% | 5.79 |
| Avid Bioservices, Inc. (CDMO) | 0.93% | $787.30M | 31.92% | N/A | N/A |
| INmune Bio, Inc. (INMB) | 0.92% | $120.62M | -100.00% | N/A | 1,861.00 |
| BioVie, Inc. (BIVI) | 0.88% | $49.04M | N/A | N/A | N/A |
| Ikena Oncology, Inc. (IKNA) | 0.88% | $82.04M | -100.00% | N/A | -70.03 |
| Voyager Therapeutics, Inc. (VYGR) | 0.87% | $338.13M | 433.79% | 95.40% | 0.23 |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.87% | $7.31M | N/A | N/A | N/A |
| Enzo Biochem, Inc. (ENZ) | 0.87% | $55.38M | 2.72% | 45.86% | 0.13 |
| XBiotech, Inc. (XBIT) | 0.86% | $202.11M | N/A | N/A | N/A |
| Nuvation Bio, Inc. (NUVB) | 0.85% | $914.81M | N/A | -130.67% | 40.94 |
| Stoke Therapeutics, Inc. (STOK) | 0.85% | $702.34M | 47.94% | 77.30% | 27.38 |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.84% | $114.85M | N/A | 45.18% | 69.16 |
| BioAtla, Inc. (BCAB) | 0.82% | $77.84M | N/A | 97.93% | 2.71 |
| Jasper Therapeutics, Inc. (JSPR) | 0.82% | $334.68M | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR) | 0.82% | $419.21M | N/A | N/A | N/A |
| Immunome, Inc. (IMNM) | 0.82% | $867.59M | -18.37% | 80.38% | 63.46 |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.81% | $45.89M | N/A | N/A | N/A |
| CARA Therapeutics, Inc. (CARA) | 0.79% | $14.95M | -47.47% | 97.14% | 2.00 |
| Aspira Women's Health, Inc. (AWH) | 0.79% | $12.12M | 1.80% | 60.04% | 1.39 |
| Aldeyra Therapeutics, Inc. (ALDX) | 0.79% | $315.02M | N/A | N/A | N/A |
| LAVA Therapeutics NV (LVTX) | 0.79% | $38.26M | -100.00% | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI) | 0.79% | $174.43M | N/A | N/A | N/A |
| Compugen Ltd. (CGEN) | 0.78% | $145.94M | N/A | 78.98% | 0.88 |
| MiNK Therapeutics, Inc. (INKT) | 0.77% | $26.19M | N/A | N/A | N/A |
| Spyre Therapeutics, Inc. (AGLE) | 0.77% | $1.56B | N/A | N/A | N/A |
| Cyclo Therapeutics, Inc. (CYTH) | 0.77% | $17.81M | -52.82% | -268.79% | 38.98 |
| Spero Therapeutics, Inc. (SPRO) | 0.76% | $62.97M | -66.56% | N/A | 0.01 |
| Heron Therapeutics, Inc. (HRTX) | 0.75% | $267.69M | 4.38% | 71.17% | 2.99 |
| Anixa Biosciences, Inc. (ANIX) | 0.74% | $94.61M | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC) | 0.73% | $119.89M | 434.46% | -316.81% | 0.49 |
| ProKidney Corp. (DNAC) | 0.73% | $595.09M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.73% | $27.49M | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB) | 0.73% | $159.44M | -100.00% | N/A | 2,675.13 |
| Humacyte, Inc. (HUMA) | 0.72% | $548.13M | N/A | N/A | N/A |
| Akoya Biosciences, Inc. (AKYA) | 0.72% | $116.47M | -25.39% | 62.32% | 2.12 |
| Rani Therapeutics Holdings, Inc. (RANI) | 0.72% | $109.11M | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN) | 0.70% | $69.89M | -34.10% | 14.21% | -4.09 |
| Precigen, Inc. (PGEN) | 0.69% | $228.76M | -30.89% | -39.24% | 60.16 |
| Trevi Therapeutics, Inc. (TRVI) | 0.69% | $204.46M | N/A | N/A | N/A |
| BioXcel Therapeutics, Inc. (BTAI) | 0.67% | $21.24M | -37.24% | -482.71% | 39.74 |
| Vaxart, Inc. (VXRT) | 0.66% | $142.24M | 134.79% | 77.70% | 9.40 |
| OncoCyte Corp. (OCX) | 0.66% | $42.09M | -73.19% | -233.04% | 56.01 |
| Cognition Therapeutics, Inc. (CGTX) | 0.66% | $18.01M | N/A | N/A | N/A |
| IO Biotech, Inc. (IOBT) | 0.66% | $55.65M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.64% | $300.67M | N/A | N/A | -1.22 |
| Omega Therapeutics, Inc. (OMGA) | 0.64% | $55.37M | 214.32% | -18.64% | 20.35 |
| Carisma Therapeutics, Inc. (SESN) | 0.62% | $28.92M | -11.55% | 78.23% | 0.85 |
| Galectin Therapeutics, Inc. (GALT) | 0.61% | $120.25M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 0.61% | $91.98M | N/A | N/A | N/A |
| Nautilus Biotechnology, Inc. (NAUT) | 0.60% | $264.94M | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC) | 0.60% | $304.24M | 38.75% | 86.62% | 6.19 |
| Curis, Inc. (CRIS) | 0.59% | $33.53M | 3.46% | 97.17% | 4.91 |
| AlloVir, Inc. (ALVR) | 0.59% | $58.04M | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB) | 0.58% | $15.25M | -50.02% | -10.12% | 9.21 |
| Co-Diagnostics, Inc. (CODX) | 0.58% | $26.91M | -91.58% | -213.54% | 0.68 |
| Solid Biosciences, Inc. (SLDB) | 0.57% | $201.77M | N/A | N/A | N/A |
| Affimed NV (AFMD) | 0.55% | $35.33M | -92.02% | N/A | 43.85 |
| Foghorn Therapeutics, Inc. (FHTX) | 0.55% | $348.01M | -55.33% | 91.03% | 13.89 |
| Compass Pathways Plc (CMPS) | 0.55% | $310.63M | N/A | N/A | N/A |
| Adaptimmune Therapeutics Plc (ADAP) | 0.55% | $160.21M | 467.86% | 93.11% | 0.75 |
| TScan Therapeutics, Inc. (TCRX) | 0.53% | $177.72M | -73.01% | 2.10% | 43.83 |
| Bionano Genomics, Inc. (BNGO) | 0.53% | $24.79M | -34.83% | -139.07% | 1.15 |
| Precision BioSciences, Inc. (DTIL) | 0.53% | $44.11M | -95.61% | -75.52% | -0.07 |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.53% | $11.18M | -9.84% | 33.25% | 1.70 |
| Fate Therapeutics, Inc. (FATE) | 0.52% | $259.68M | 58.13% | -49.87% | 15.93 |
| Neoleukin Therapeutics, Inc. (NLTX) | 0.51% | $308.36M | N/A | N/A | 632.97 |
| Agenus, Inc. (AGEN) | 0.51% | $78.70M | 3.28% | 86.09% | 3.21 |
| PepGen Inc. (PEPG) | 0.49% | $168.19M | N/A | N/A | N/A |
| 23andMe Holding Co. (ME) | 0.49% | $103.87M | -11.86% | 35.53% | 0.63 |
| Black Diamond Therapeutics, Inc. (BDTX) | 0.45% | $138.07M | N/A | N/A | N/A |
| HOOKIPA Pharma, Inc. (HOOK) | 0.45% | $23.85M | -31.51% | 85.12% | -0.06 |
| Invivyd, Inc. (ADGI) | 0.44% | $71.77M | N/A | 85.32% | 1.44 |
| Nkarta, Inc. (NKTX) | 0.42% | $175.72M | N/A | N/A | N/A |
| Prelude Therapeutics, Inc. (PRLD) | 0.34% | $53.38M | N/A | 86.50% | 7.18 |
| Instil Bio, Inc. (TIL) | 0.33% | $163.08M | N/A | N/A | N/A |
| Climb Bio, Inc. (ELYM) | 0.32% | $207.05M | N/A | N/A | N/A |
| Shattuck Labs, Inc. (STTK) | 0.31% | $62.06M | 336.88% | 68.20% | 14.14 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.11% | $6.54M | -100.00% | N/A | 224.15 |
| Gritstone bio, Inc. (GRTS) | 0.01% | $0.77M | -85.75% | -2,707.02% | 270.26 |
| eFFECTOR Therapeutics, Inc. (EFTR) | <0.01% | $0.00M | N/A | N/A | N/A |
| Vaxxinity, Inc. (VAXX) | <0.01% | $0.01M | N/A | N/A | N/A |